Narang Sunil K, Alam Nasra N, Köckerling Ferdinand, Daniels Ian R, Smart Neil J
Exeter Surgical Health Services Research Unit (HeSRU), Royal Devon and Exeter Hospital , Exeter, Devon , UK.
Department of Surgery, Center for Minimally Invasive Surgery, Vivantes Hospital, Academic Teaching Hospital of Charité Medical School , Berlin , Germany.
Front Surg. 2016 Sep 5;3:49. doi: 10.3389/fsurg.2016.00049. eCollection 2016.
Perineal hernia (PerH) following abdominoperineal excision (APE) procedure is a recognized complication. PerH was considered an infrequent complication of APE procedure; however, PerH rates of up to 45% have been reported in recent publications following a laparoscopic APE procedure. Various methods of repair of PerH with the use of synthetic meshes or myocutaneous flap have been described, although there is no general agreement on an optimal strategy. The use of biological meshes for different operations is growing in popularity, and these have been promoted as being superior and safer when compared to synthetic meshes. Although the use of biologics is becoming popular claims of better outcomes are largely unsupported by evidence. The aim of this systematic review is to evaluate the currently available evidence supporting the use of biologic or biosynthetic meshes for the repair of PerH that develop following an APE.
A systematic review of all English language literature relevant to repair of PerH following APE with biologic or biosynthetic mesh published between January 1, 2000 and July 31, 2016 was carried out using MEDLINE, EMBASE, and the Cochrane Library of Systematic Reviews for relevant literature. Searches were performed using a combination of Medical Subject Headings (MeSH) terms and text words "PerH," "APE," "morbidity," "biologics," "biosynthetic," and "hernia." Studies in which the use of biological meshes was not reported were excluded from the review. Various outcome measures, including operative technique, complication rates, recurrence rates, type of mesh, management of recurrences, and risk factors, were extracted. Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009) was used to assess the quality of evidence.
The systematic review of the literature identified three case reports, four case series, and one pooled analysis that were included in the final review. Overall, these studies were of poor quality providing level 4 evidence. Various different approaches and techniques of repair of PerH were described; however, it was difficult to extract information with regard to the primary and secondary outcome measures.
There is no general agreement to the optimal operative strategy to repair PerH following an APE. There is insufficient evidence to recommend any specific operative approach or repair technique for PerH following an APE.
腹会阴联合切除术(APE)后发生会阴疝(PerH)是一种公认的并发症。会阴疝曾被认为是APE手术的罕见并发症;然而,最近的出版物报道腹腔镜APE手术后会阴疝发生率高达45%。尽管对于最佳治疗策略尚无普遍共识,但已描述了使用合成补片或肌皮瓣修复会阴疝的各种方法。生物补片在不同手术中的应用越来越普遍,与合成补片相比,它们被宣传为更优越、更安全。尽管生物补片的使用越来越普遍,但关于其能带来更好疗效的说法在很大程度上缺乏证据支持。本系统评价的目的是评估目前支持使用生物或生物合成补片修复APE后发生的会阴疝的现有证据。
使用MEDLINE、EMBASE和Cochrane系统评价图书馆,对2000年1月1日至2016年7月31日期间发表的所有与使用生物或生物合成补片修复APE后会阴疝相关的英文文献进行系统评价,以查找相关文献。搜索使用医学主题词(MeSH)术语和文本词“PerH”“APE”“发病率”“生物制品”“生物合成”和“疝”的组合进行,但未报告使用生物补片的研究被排除在评价之外。提取了各种结局指标,包括手术技术、并发症发生率、复发率、补片类型、复发处理和危险因素。使用牛津循证医学中心-证据级别(2009年3月)评估证据质量。
对文献的系统评价确定了3篇病例报告、4篇病例系列和1项汇总分析,最终纳入评价。总体而言,这些研究质量较差,提供的是4级证据。描述了会阴疝修复的各种不同方法和技术;然而,很难提取有关主要和次要结局指标的信息。
对于APE后会阴疝的最佳手术策略尚无普遍共识。没有足够的证据推荐APE后会阴疝的任何特定手术方法或修复技术。